Zota Health Care Limited

NSE ZOTA.NS

Zota Health Care Limited Net Cash Used For Investing Activities for the year ending March 31, 2024: USD -1.55 M

Zota Health Care Limited Net Cash Used For Investing Activities is USD -1.55 M for the year ending March 31, 2024, a -186.47% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.

Zota Health Care Limited Net Cash Used For Investing Activities for the year ending March 31, 2023 was USD 1.79 M, a 150.97% change year over year.
Zota Health Care Limited Net Cash Used For Investing Activities for the year ending March 31, 2022 was USD -3.51 M, a -772.73% change year over year.
Zota Health Care Limited Net Cash Used For Investing Activities for the year ending March 31, 2021 was USD 521.77 K, a 211.40% change year over year.
Zota Health Care Limited Net Cash Used For Investing Activities for the year ending March 31, 2020 was USD -468.39 K, a -136.88% change year over year.

Key data

Date	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure

NSE: ZOTA.NS

Zota Health Care Limited

CEO	Dr. Sujit Paul
IPO Date	May 10, 2017
Location	India
Headquarters	Zota House
Employees	445
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India. It offers generic drugs, over-the-counter products, ayurvedic products, and nutraceutical products. The company provides various medicines for chronic illnesses, including heart disease, diabetes, thyroid, and others. As of March 31, 2021, it operated 591 retail stores under the DAVAINDIA name in 24 states of India. The company was founded in 1995 and is headquartered in Surat, India.

Key trends

Past 5 years